Valuation
- Market cap
- 95,539,000
- Revenue TTM
- $17,590,000
- Net income TTM
- $-21,690,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- -123.31%
- Debt to equity
- 0.00
Trading
- Volume
- 2,050,400
- Avg volume
- 1,855,406
- Day's range
- $2.00 – $2.24
- Shares out
- 46,154,000
- Stochastic %K
- 15%
- Beta
- 0.53
- Analysts
- Moderate Buy
- Price target
- $4.00
Company profile
MindWalk operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk in Sep...
Show more
MindWalk operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 800-620-4187
- Website
- https://www.ipatherapeutics.com
- Address
- Industrious 823 Congress Ave, Suite 300, Austin, United States
Latest news
No headlines yet.
